Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gail Cross

Burnet Institute

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Articles (11)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Han Nguyen

Karolinska Institutet

SWEDEN

View details

Geraint Davies

Professor of Infection Pharmacology

University of Liverpool

UNITED KINGDOM

View details

Angela Crook

University College London

UNITED KINGDOM

View details

Catherine Ong

Associate Professor

National University of Singapore (NUS)

SINGAPORE

View details

Jane Greig

co-head Pacific Infectious Diseases Working Group

Burnet Institute

AUSTRALIA

View details

Ibrahim Abubakar

Dean (Faculty of Population Health Sciences)

University College London

UNITED KINGDOM

View details

Paul Anantharajah Tambyah

National University of Singapore (NUS)

SINGAPORE

View details

Ibrahim Abubakar

Dean

University College London

UNITED KINGDOM

View details

Jody Phelan

Assistant Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gail Cross

Research Interests

Explore related searches

Articles (11)

We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness

Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial.

Diffuse syphilitic periostitis in a patient living with human immunodeficiency virus: A case report and review of syphilitic periostitis/protean syphilis

New drugs for the management of tuberculosis

PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment

Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial

Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials

Treatment Strategy for Rifampin-Susceptible Tuberculosis.

Continued demographic shifts in hospitalised patients with COVID-19 from migrant workers to a vulnerable and more elderly local population at risk of severe disease

Standards for clinical trials for treating TB

Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial

Collaborators (9)

Han Nguyen

Geraint Davies

Angela Crook

Catherine Ong

Jane Greig

Ibrahim Abubakar

Paul Anantharajah Tambyah

Ibrahim Abubakar

Jody Phelan

Make your next move.